OVERALL EFFICACY WITH NUCALA
ADVANCE PATIENT OUTCOMES WITH NUCALA
©2023 GSK group of companies or its licensor
Trade marks are owned by or licensed to the GSK group of companies
PM-NO-MPL-WCNT-230008 September 2023
Er du ikke helsepersonell? Besøk våre hjemmesider
Er du ikke helsepersonell?
Besøk gjerne våre sider for publikum.
59
©2023 GSK group of companies or its licensor
Trade marks are owned by or licensed to the GSK group of companies
PM-NO-MPL-WCNT-230008 September 2023